Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
1245300
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise of stock acquisition rights with provisions for adjustment to the exercise price (monthly exercise status)
発行・処分する株式数1,245,300Shares
New shares: 1,245,300 shares
発行済株式総数
3.09% (number of shares issued across all series / number of listed shares as of the payment date for the issue)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥100.0, ¥101.8, ¥104.7 and ¥105.6. Details of the adjustment provisions and the floor price: Not disclosed
Number of Stock Acquisition Rights
Total issued: 79,935 rights (12,453 rights, or 15.57% of the total issued); unexercised at the end of the preceding month: 21,135 rights; unexercised at the end of the relevant month: 8,682 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations. The number of shares issued across all series was 1,245,300, the number of listed shares as of the payment date for the issue was 40,330,067, and the exercise ratio was 3.09%.
Most recent equity financing
The 10th Series of Stock Acquisition Rights (with Exercise Price Adjustment Clauses) issued on 31 March 2025
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise of stock acquisition rights with provisions for adjustment to the exercise price (monthly exercise status) |
| Number of shares to be issued or disposed of | New shares: 1,245,300 shares |
| Dilution Rate | 3.09% (number of shares issued across all series / number of listed shares as of the payment date for the issue) |
| Total number of issued shares | 46,341,767 shares (as of the end of the month preceding the relevant month) → Not disclosed |
| Exercise price | ¥100.0, ¥101.8, ¥104.7 and ¥105.6. Details of the adjustment provisions and the floor price: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 79,935 rights (12,453 rights, or 15.57% of the total issued); unexercised at the end of the preceding month: 21,135 rights; unexercised at the end of the relevant month: 8,682 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations. The number of shares issued across all series was 1,245,300, the number of listed shares as of the payment date for the issue was 40,330,067, and the exercise ratio was 3.09%. |
| Most recent equity financing | The 10th Series of Stock Acquisition Rights (with Exercise Price Adjustment Clauses) issued on 31 March 2025 |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company is reporting the monthly exercise status in August 2026 of the 10th Series of Stock Acquisition Rights (with Exercise Price Adjustment Provisions) issued on 31 March 2025.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.